Artiva Share Price

Artiva Share Price

NASDAQ: ARTV | Micro Cap | Healthcare
$3.79
-$0.04 (-1.17%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Artiva Stock Performance

Open
$3.85
Prev. Close
$3.83
Circuit Range
N/A
Day Range
$3.77 - $3.92
Year Range
$3.01 - $14.47
Volume
99,491
Average Traded
$3.83

Artiva Share Price Today

As of 23 November 2026, Artiva Biotherapeutics, Inc.'s share price is $3.79. The stock opened at $3.85, compared to its previous close of $3.83. During today's trading session, Artiva Biotherapeutics, Inc.'s share price traded between $3.77 and $3.92, with an average price of $3.85. Over the past 52 weeks, the stock has recorded a high of $14.47 and a low of $3.01. In terms of performance, Artiva Biotherapeutics, Inc.'s share price has declined by 52.09% over the last six months and is up 3.55% on a year-on-year basis.

Artiva Share Price Chart

Line chart of the Artiva price trend over the selected period. The price fell overall, ranging from 3.78 to 3.92, ending at 3.79.
$3.77$3.92
L
Show Current Price
H

Artiva Stock Fundamentals & Key Indicators

Market Cap
$92.64M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.98
Revenue (TTM)
$0.00
Return On Equity (TTM)
-30.59%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-38.76%

Artiva Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$20.77-$23.52-$25.01-$28.82
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-13.24%-6.34%-15.23%

Artiva Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.25$0.00
Net Profit-$65.37-$83.87
Net Profit Margin-26148.00%N/A
Income ChangeN/A-28.30%

Artiva Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets18.2720.95
Current Assets112.67188.63
Total Assets130.94209.58
Non Current Liabilities7.8810.69
Current Liabilities13.0912.25
Total Liabilities20.9722.94
Shareholders' Equity109.97186.64

Artiva Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-76.75-55.03
Investing63.41-120.46
Financing0.01162.23

About Artiva

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).

Artiva Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$4.19
$3.79
-9.45%
Oct 2026
$6.92
$4.18
-41.21%
Sep 2026
$11.06
$7.11
-40.50%
Aug 2026
$10.08
$11.95
+18.61%
Jul 2026
$9.75
$10.07
+3.76%
Jun 2026
$7.68
$9.71
+22.76%
May 2026
$9.90
$7.91
-22.98%
Apr 2026
$6.35
$10.27
+59.10%
Mar 2026
$5.54
$6.46
+8.31%
Feb 2026
$3.99
$5.96
+52.43%
Jan 2026
$4.17
$3.91
-8.64%
Dec 2025
$3.58
$4.28
+16.94%

Artiva Share Price FAQs